Lucigen Gets $226K SBIR Grant from NIH | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Wisconsin biotech firm Lucigen said on Monday it has received a $226,401 Small Business Innovation Research Phase I grant from the National Institutes of Health to develop genomic tools for use in discovering and characterizing new therapeutics from fungi.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.